Last reviewed: July 9, 2026
Last updated: July 9, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Many patients considering GLP-1 receptor agonist therapy assume they need daily injections, but the reality is quite different. Ozempic and similar medications are designed as weekly injections, which means you administer one dose every seven days rather than multiple times per week.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
How Often Is Ozempic Actually Injected?
Ozempic is a once-weekly injection medication, meaning patients inject themselves one time every seven days on the same day each week. This schedule differs significantly from insulin therapy, which typically requires multiple daily injections or pump delivery. The weekly formulation allows the active ingredient semaglutide to circulate through your system continuously for seven days before requiring a new dose.
The convenience of weekly dosing has made GLP-1 medications popular for weight management and diabetes control. Patients often find it easier to remember a single weekly appointment with their medication rather than managing multiple daily doses. This dosing pattern also reduces injection-related anxiety for many people who might otherwise avoid injectable therapies.
Why Weekly Injections Instead of Daily Doses?
Semaglutide has a long half-life, meaning it remains active in your body for an extended period after injection. This pharmacological property allows the medication to maintain therapeutic levels throughout the week without requiring daily administration. The drug's extended duration of action was specifically engineered to support once-weekly dosing in clinical development.
A longer-acting formulation reduces the overall medication burden on patients and improves adherence to treatment regimens. Clinical studies have shown that weekly injection schedules lead to better long-term compliance compared to daily or multiple-times-weekly protocols. PlexusDx compounded semaglutide injection follows this same evidence-based weekly schedule, at $189/mo month-to-month, or from $149/mo on the 6-month plan with no pricing increases as your dose is optimized.
Starting Dose and Titration Schedule
Most patients begin semaglutide therapy at a low starting dose, typically 0.25 mg, administered once weekly. Your dose may increase gradually every four weeks depending on your tolerance and weight loss response. This titration approach minimizes side effects while allowing your body time to adjust to the medication's effects on appetite and metabolism.
The dose escalation continues until you reach your optimal therapeutic dose, which varies based on individual factors including baseline weight, metabolic health, and genetic predisposition to GLP-1 receptor signaling. PlexusDx's Precision Peptide Genetic Test can identify your genetic variants in the GLP1R gene and other pathways that influence your response to semaglutide therapy, helping guide personalized dosing decisions.
Compounded Semaglutide vs. Brand-Name Ozempic Injections
PlexusDx offers compounded semaglutide injection from licensed 503A compounding pharmacies, which provides the same active ingredient and weekly injection schedule as brand-name Ozempic. Compounded medications allow access without insurance requirements or membership fees, with HSA and FSA eligibility available. Your dose may need to go up as you progress through your weight loss journey, but your price remains flat at $149 per month.
Compounded semaglutide undergoes rigorous quality testing and must meet the same pharmaceutical standards as FDA-approved products, though the compounded formulation itself is not FDA-approved. PlexusDx serves all 50 states and coordinates your care with telehealth providers to monitor your progress and adjust your weekly injection dose safely. Many patients find compounded options provide greater flexibility in dosing adjustments compared to commercially available pre-filled pens.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Do I really only need to inject semaglutide once per week?
Yes, semaglutide is a once-weekly injection medication. You inject yourself one time every seven days on the same day each week. This weekly schedule is based on the drug's long half-life, which keeps it active in your system for the full seven-day period without requiring daily doses.
Can I switch to daily injections if weekly doesn't work for me?
The once-weekly formulation is the standard dosing design for semaglutide, and changing to daily injections would require a different medication class. If you experience side effects or adherence challenges with weekly injections, PlexusDx also offers oral semaglutide as an alternative daily option that may suit your preferences better.
How much does a month of semaglutide injections cost at PlexusDx?
PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) with no pricing changes as your dose is adjusted during titration. The flat monthly price applies regardless of dose level, and the medication is HSA/FSA eligible with no insurance requirements or membership fees.
What are the common side effects of weekly semaglutide injections?
Early side effects often include nausea, vomiting, diarrhea, and constipation, which typically improve as your body adjusts over weeks. More serious but rare side effects include pancreatitis symptoms and gallbladder issues. Most patients tolerate weekly injections well once they progress past the initial titration phase.
How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?
Yes, PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month) analyzes 14 metabolic pathways and 150+ genetic insights, including your GLP1R variant. Genetic markers at rs6923761 and other loci influence how effectively semaglutide works for you, allowing more personalized dosing from the start.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is It Safe to Take Ozempic to Lose Weight?
Navigating Your Path to Health: How Long Do You Take Wegovy for Sustainable Weight Management?